Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Invested Capital (2021 - 2025)

Rxo (RXO) has disclosed Invested Capital for 5 consecutive years, with $1.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 1.77% year-over-year to $1.9 billion, compared with a TTM value of $1.9 billion through Dec 2025, down 1.77%, and an annual FY2025 reading of $1.9 billion, down 1.77% over the prior year.
  • Invested Capital was $1.9 billion for Q4 2025 at Rxo, down from $2.0 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $2.0 billion in Q3 2024 and bottomed at $949.0 million in Q1 2024.
  • Average Invested Capital over 5 years is $1.4 billion, with a median of $1.1 billion recorded in 2021.
  • The sharpest move saw Invested Capital fell 12.93% in 2023, then skyrocketed 109.8% in 2025.
  • Year by year, Invested Capital stood at $1.1 billion in 2021, then decreased by 2.62% to $1.0 billion in 2022, then fell by 8.54% to $953.0 million in 2023, then skyrocketed by 107.76% to $2.0 billion in 2024, then decreased by 1.77% to $1.9 billion in 2025.
  • Business Quant data shows Invested Capital for RXO at $1.9 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.